Philadelphia Attorneys New Jersey Attorneys Pennsylvania Lawyers Golomb & Honik P.C.

Actos Attorneys

Philadelphia, Pennsylvania, New Jersey, Nationwide

The diabetes drug Actos has been prescribed to millions of patients since it was approved by the Food and Drug Administration in 1999. However, increasing evidence links the use of Actos to a heightened risk for bladder cancer.

The Philadelphia dangerous drug attorneys at Golomb & Honik are actively investigating claims from diabetics who developed bladder cancer after using Actos. At particularly high risk are patients who used Actos for 12 months or longer.

 

The Risks of Actos

Intended to help people with type 2 diabetes control blood-sugar levels, Actos increases insulin sensitivity, thereby encouraging sugar to diffuse from the blood to the body instead of building up in the blood. In the years following the FDA’s approval of Actos, reports of Actos users suffering from bladder cancer began to mount.

In 2011, the FDA determined there was a significant risk of bladder cancer associated with long-term use of Actos and required Actos manufacturer Takeda Pharmaceuticals to issue a new warning with the drug’s packaging that states diabetics who use Actos for longer than 12 months face an increased risk of bladder cancer. Actos has also been linked to a heightened risk for heart failure and diabetic macular edema.

Symptoms of Bladder Cancer

Typically, bladder cancer can be treated if diagnosed in its early stages. However, bladder cancer also has a high rate of recurrence and can be deadly.

Bladder cancer symptoms include:

  • Abdominal pain
  • Back pain
  • Bloody urine
  • Frequent urination
  • Painful urination
  • Urinary tract infection

Following its latest review of Actos-related data, the FDA advised doctors to not prescribe the medication to patients also being treated for bladder cancer and to not prescribe the higher dose of Actos to new patients.

If you developed bladder cancer after using the prescription drug Actos to help control your diabetes, please contact the Philadelphia dangerous drug attorneys at Golomb & Honik for your no-cost case evaluation. We welcome clients from Pennsylvania, New Jersey and across the United States.

Golomb & Honik

215.985.9177 | 855.889.5389

1515 Market Street , Suite 1100 Philadelphia, PA 19102